4.088USD-4.03%Mkt Cap: 235.44M USDP/E: —Last update: 2026-06-01
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the Uni…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap235.44M USD
Enterprise Value109.66M USD
Revenue (TTM)28.22M USD
Gross Profit-53.88M USD
Net Income (TTM)-74.28M USD
Revenue/Share0.4370 USD
Last Price4.088 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees106
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.61
PEG—
EV/EBITDA-1.41
EV/Revenue3.89
P/S8.90
P/B-3.29
EPS (TTM)-1.17
EPS (Forward)-0.93
52W Range
3.27022% of range6.950
52W High6.950 USD
52W Low3.270 USD
Profitability
Gross Margin-190.88%
Oper. Margin-660.33%
EBITDA Margin-276.45%
Profit Margin-240.33%
ROE68.46%
ROA-37.50%
Growth
Revenue Growth-45.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-86.10M USD
CapEx (TTM)50.00K USD
FCF Margin-130.83%
FCF Yield-15.68%
Net Debt-141.64M USD
Net Debt/EBITDA1.82
Balance Sheet
Debt/Equity-0.38
Current Ratio2.92
Quick Ratio2.85
Book Value/Sh-1.3010 USD
Cash/Share3.128 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)11.44 USD
Target Range9.000 USD – 14.00 USD
# Analysts9
Ownership
Shares Out.58.71M
Float27.41M
Insiders17.94%
Institutions76.49%
Short Interest
Short Ratio10.4d
Short % Float4.19%
Short % Out.2.28%
Shares Short1.34M
Short (prev mo.)1.38M
Technical
SMA 504.679 (-12.6%)
SMA 2004.954 (-17.5%)
Beta2.97
S&P 52W Chg27.94%
Avg Vol (30d)131.79K
Avg Vol (10d)188.86K
Technical Indicators
RSI (14)46.5
MACD-0.1632
MACD Signal-0.2153
MACD Hist.+0.0521
BB Upper4.859 USD
BB Middle4.244 USD
BB Lower3.628 USD
BB Width29.00%
ATR (14)0.2768 USD
Vol Ratio (20d)0.45x